Showing results (61-70 of 340) with videos related to
Sort By:
Pageof 34
British Journal of Clinical Pharmacology|April 16, 2015
The renal protective effect of angiotensin receptor blockers depends on intra-individual response variation in multiple risk markersBauke Schievink, Dick de Zeeuw, Hans-Henrik Parving, et al.Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|May 1, 2002
Do severe systemic sequelae of proteinuria modulate the antiproteinuric response to chronic ACE inhibition?Hendrik Bos, Robert H Henning, Paul E De Jong, et al.British Journal of Clinical Pharmacology|July 15, 2016
Blood pressure-lowering effects of sulodexide depend on albuminuria severity: post hoc analysis of the sulodexide microalbuminuria and macroalbuminuria studiesRik H G Olde Engberink, Hiddo J L Heerspink, Dick de Zeeuw, et al.Diabetes, Obesity & Metabolism|August 16, 2019
Association between individual cholesterol and proteinuria response and exposure to atorvastatin or rosuvastatinMarjolein Y A M Kroonen, Jasper Stevens, Dick de Zeeuw, et al.European Journal of Pharmacology|April 16, 2008
Immune modulation and graft protection by gene therapy in kidney transplantationMaria Sandovici, Leo E Deelman, Dick de Zeeuw, et al.Therapeutic Advances in Endocrinology and Metabolism|February 22, 2021
A novel drug response score more accurately predicts renoprotective drug effects than existing renal risk scoresNienke M A Idzerda, Sok Cin Tye, Dick de Zeeuw, et al.Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|December 25, 2012
Is albuminuria screening and treatment optimal in patients with type 2 diabetes in primary care? Observational data of the GIANTT cohortMerel E Hellemons, Petra Denig, Dick de Zeeuw, et al.Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|June 22, 2013
Effects of paricalcitol on calcium and phosphate metabolism and markers of bone health in patients with diabetic nephropathy: results of the VITAL studyDaniel W Coyne, Dennis L Andress, Michael J Amdahl, et al.Nature Reviews. Nephrology|October 17, 2012
Management of hyperkalaemia consequent to mineralocorticoid-receptor antagonist therapySara S Roscioni, Dick de Zeeuw, Stephan J L Bakker, et al.Journal of Cardiovascular Pharmacology|October 25, 2003
High dietary sodium blunts affects of angiotensin-converting enzyme inhibition on vascular angiotensin I-to-angiotensin II conversion in ratsMenno J A Kocks, Hendrik Buikema, Simone Gschwend, et al.Pageof 34